We describe the mechanisms underlying the vascular contraction induced by succinate.
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Value of the data
Succinate displays a direct contractile effect on the vasculature. The contraction induced by succinate is partially mediated by GPR91 receptors. The data provide insights into the mechanisms underlying the contractile effect of succinate.
Data
Data describes the contractile action of succninate. Fig. 1 shows representative traces of the contractile effect of succinate on endothelium-intact and endothelium-denuded aortic rings from Wistar rats and C57BL/6 or GPR91 À / À mice. The maximal contraction induced by succinate in endothelium-intact and endothelium-denuded aortas isolated from Wistar rats and C57BL/6 or GPR91-deficient mice are represented on Fig. 2 . The effects of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contraction are represented on Fig. 3 . The contractile response induced by succinate on endothelium-intact and endothelium-denuded rat aortic rings was reduced by indomethacin, H7, verapamil and tiron (Fig. 4 ).
Experimental design, materials and methods
Male Wistar rats (230-250 g) and C57BL/6 or GPR91 À / À mice (20-25 g) were anaesthetized
intraperitoneally with urethane at 1.25 g/kg (Sigma-Aldrich, St. Louis, MO, USA) and the thoracic aorta was mounted in organ chambers [1] . The contraction induced by succinate (50-130 mmol/L) was evaluated in endothelium-intact and endothelium-denuded rat aortic rings. In another set of experiments, the contractile effect of succinate (0.03-130 mmol/L) was evaluated in endotheliumintact and endothelium-denuded aortic rings from C57BL/6 and GPR91 À / À mice [2] .
In another set of experiments, the contractile response induced by succinate was evaluated in endothelium-intact or endothelium-denuded rat aortic rings incubated for 30 min with one of the following drugs: SB203508 (10 mmol/L, p38MAK inhibitor), SP600125 (10 mmol/L, JNK inhibitor), PD98059 (10 mmol/L, ERK1/2 inhibitor), Y27632 (10 mmol/L, Rho-kinase inhibitor), H7 (10 μmol/L, protein kinase C inhibitor), indomethacin (10 μmol/L, non-selective cyclooxygenase inhibitor), tiron (superoxide anion scavenger, 100 μmol/L) or verapamil (1 μmol/L, Ca 2 þ channel blocker).
Results are expressed as means 7standard errors of the mean (S.E.M.). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Newman-Keuls multiple comparison test. P values of less than 0.05 were considered significant. 
